Most Recent
BHP has won its argument that shareholders who did not purchase their stock while trading on one of the three exchanges on which the mining giant is listed are excluded from a securities class action over the collapse of a Brazil tailings dam.
A franchisee class action against United Petroleum over the installation of allegedly loss-making Pie Face stores at its franchise sites has succeeded in fending off the petrol company’s bid for security, with a judge agreeing it would have a chilling effect on the unfunded case.
General Motors is stuck with the full costs of the applicant in a Holden dealers' class action as part of a settlement with the dealership, despite arguing it had intended by its offer to pay the costs incurred only by the lead plaintiff itself.
The Office of the Australian Information Commissioner has brought civil penalty proceedings accusing pathology services provider Australian Clinical Labs of failing to take steps to prevent a February 2022 data breach that affected millions of patients.
Ten has questioned whether presenter Lisa Wilkinson should have separate representation in defending a defamation case by accused rapist Bruce Lehrmann, as it responds to a dispute over a promise to cover her legal bill.
EnergyAustralia has hit back at a lawsuit by Australian parents accusing it of misleading customers, saying it was "valid" to market its products involving a carbon offset scheme as 'carbon neutral'.
The owner of a small jewellery retailer in central Sydney must pay a younger female employee $237,985 for sexual harassment after he slapped her on the buttocks and confessed romantic feelings for her, a judge has found.
Hey Hey It's Saturday host and producer Daryl Somers is suing the Seven Network for broadcasting footage of a duet performed by John Farnham and Tom Jones on the iconic TV show 33 years ago.
The communications regulator has slapped Kmart Australia with a $1.3 million penalty for sending more than 200,000 marketing emails to customers who had previously unsubscribed from its communications.
Novartis unit Sandoz AG has lost its bid to revoke Bayer’s patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giant’s patents were valid.